Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed Dec 3, 2015 · 10-Q · 64 days after period end · 0001615774-15-003559
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Revenue | — | $13.48K |
| Net Income | -$816.56K | -$78.33K |
| EPS Diluted | -$0.03 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Dec 3, 2015 · 64 d after period end
